28 Nov 2014 07:00
OMEGA DIAGNOSTICS GROUP PLC
("Omega" or the "Company" or the "Group")
Director's Dealing
Omega (AIM: ODX), the medical diagnostics company focused on allergy, food intolerance and infectious disease, announces that David Evans, Non-Executive Chairman of the Company, purchased 173,500 ordinary shares in the Company at 15p per share on 27 November 2014.
Following this transaction, Mr Evans' total beneficial holding has increased to 3,043,634 ordinary shares representing 2.8 per cent of the issued ordinary share capital of the Company.
Contacts:
Omega Diagnostics Group PLC | Tel: 01259 763 030 or www.omegadiagnostics.com |
Andrew Shepherd, Chief Executive | |
Kieron Harbinson, Group Finance Director Jag Grewal, Group Sales and Marketing Director | |
finnCap Ltd | Tel: 020 7220 0500 |
Geoff Nash/Christopher Raggett (Corporate Finance) Mia Gardner (Corporate Broking) | |
Walbrook PR Limited | Tel: 020 7933 8780 or omega@walbrookpr.com |
Paul McManus | Mob: 07980 541 893 |
Lianne Cawthorne | Mob: 07584 391 303 |